thinprep cytology test (tct) preservation solution (Hologic Gen-Probe)
90
Structured Review
Hologic Gen-Probe
thinprep cytology test (tct) preservation solution
Thinprep Cytology Test (Tct) Preservation Solution, supplied by Hologic Gen-Probe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thinprep+pap+test+solution/thinprep+cytology+test++tct++preservation+solution/pm32150350-38-13-17
Average 90 stars, based on 1 article reviews
Thinprep Cytology Test (Tct) Preservation Solution, supplied by Hologic Gen-Probe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thinprep+pap+test+solution/thinprep+cytology+test++tct++preservation+solution/pm32150350-38-13-17
Average 90 stars, based on 1 article reviews
thinprep cytology test (tct) preservation solution - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Preserving:Article Title: ALK and ROS1 rearrangement tested by ARMS-PCR in non-small-cell lung cancer patients via cytology specimens: The experience of Shanghai Pulmonary Hospital. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 81802803; Shanghai Sailing Program, Grant/Award Number: 17YF1415800 Abstract Background: Cytology specimens are the main samples used for the diagnosis of advanced lung cancer.. The objective of our study was to assess anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 receptor tyrosine kinase (ROS1) genes by an amplification refractory mutation system (ARMS)-polymerase chain reaction (PCR) using cytology specimens and to then evaluate the mutation frequency of ALK and ROS1 in non-small-cell lung cancer (NSCLC) patients.. Methods: A large cohort that consisted of 8180 NSCLC patients who were genetically tested using cytology samples or formalin-fixed and paraffin-embedded (FFPE) samples (tumor tissue or biopsy) from January 2015 to December 2018 were screened. Blocking Assay:Article Title: ALK and ROS1 rearrangement tested by ARMS-PCR in non-small-cell lung cancer patients via cytology specimens: The experience of Shanghai Pulmonary Hospital. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 81802803; Shanghai Sailing Program, Grant/Award Number: 17YF1415800 Abstract Background: Cytology specimens are the main samples used for the diagnosis of advanced lung cancer.. The objective of our study was to assess anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 receptor tyrosine kinase (ROS1) genes by an amplification refractory mutation system (ARMS)-polymerase chain reaction (PCR) using cytology specimens and to then evaluate the mutation frequency of ALK and ROS1 in non-small-cell lung cancer (NSCLC) patients.. Methods: A large cohort that consisted of 8180 NSCLC patients who were genetically tested using cytology samples or formalin-fixed and paraffin-embedded (FFPE) samples (tumor tissue or biopsy) from January 2015 to December 2018 were screened. |
